Wayback Machine
Nov DEC Jan
Previous capture 20 Next capture
2014 2015 2016
1 captures
20 Dec 15 - 20 Dec 15
sparklines
Close Help
Skip to main content

Access brought to you by: LOCKSS

Login

MD Conference Express
Advanced Search

Main menu

  • HOME
  • BROWSE BY CONFERENCE
  • BROWSE BY DISCIPLINE
    • -- All Disciplines --
    • Anesthesiology
    • Cardiology & Cardiovascular Medicine
    • Dentistry
    • Dermatology
    • Endocrinology, Diabetes & Metabolism
    • Emergency Medicine & Critical Care
    • Hematology
    • Hepatology
    • Infectious Diseases
    • Nephrology
    • Neurology
    • Nutrition
    • Obstetrics & Gynecology
    • Oncology
    • Ophthalmology
    • Orthopaedics & Sports Medicine
    • Psychiatry & Psychology
    • Pulmonary & Respiratory Medicine
    • Radiology
    • Rheumatology
    • Veterinary Medicine
  • ABOUT
    • About Us
    • International Medical Advisory Board
    • Reprints
    • Librarian resources
    • Contact us
    • Help

Ophthalmology Clinical Trials

  • Ranibizumab 0.5 mg Safe and Effective for Treatment of DME
  • Methodological Shortcomings Revealed in Clinical Guidelines for Primary Open-Angle Glaucoma
  • Intravitreal Aflibercept Has Long-Term Benefits in Treatment of DME
  • Open-Label Extension of RIDE and RISE Shows Improved Visual Outcomes Maintained without Ranibizumab Retreatment

Other Products from SAGE / CQ Press

  • SAGE Journals
  • SAGE Knowledge
  • SAGE Research Methods
  • Help
Copyright © by SAGE Publications
Online ISSN: 1559-8977